5 syllables: A, da, li, mu, mab. Stress on li.
uh-duh-LIM-yoo-mab
/ədəˈlɪmjuːmæb/
Adalimumab is pronounced uh-duh-LIM-yoo-mab (/ədəˈlɪmjuːmæb/). It has five syllables (A-da-li-mu-mab), with the stress on "li". Adalimumab is a monoclonal antibody used as a biologic medication to treat autoimmune diseases by targeting tumor necrosis factor alpha. It is administered by injection and is typically prescribed for conditions like rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. The name itself reflects its therapeutic class and molecular design rather than a clinical description.
nounAdalimumab is a monoclonal antibody used as a biologic medication to treat autoimmune diseases by targeting tumor necrosis factor alpha. It is administered by injection and is typically prescribed for conditions like rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. The name itself reflects its therapeutic class and molecular design rather than a clinical description.
- You’ll make it harder than it needs to be if you rush; take time to segment: a-dah-LEE-muh-MAB. - Specific pitfalls: misplacing stress on the first or third syllable; pronouncing the final -mab as -map or with an unreleased /b/. - Corrections: slow down to four-mora units, mark the stressed syllable, and ensure final /b/ is released. Adjust the second syllable vowel to /iː/ and keep the second syllable lengthened. - Extra tip: practice saying with a short pause after ‘a-da-’ and then continue to ‘LI-muh-MAB’ for rhythm control. - Use minimal pairs and slower speed in early practice to solidify the correct pattern.
"• A patient with rheumatoid arthritis started on Adalimumab to reduce joint inflammation."
"• The dermatologist prescribed Adalimumab for plaque psoriasis that did not respond to conventional therapy."
"• In clinical trials, Adalimumab demonstrated efficacy in suppressing disease activity."
Adalimumab is pronounced as /ˌæ.dəˈliː.məˌmæb/ in US English, with primary stress on the /liː/ syllable. The sequence breaks into a-dah-LI-muh-mab, with the 'ma' reduced in rapid speech. Accent and enunciation emphasize the second syllable and the final 'mab' /mæb/, keeping the 'b' clearly released. You can think: a-dah-LEE-muh-MAB, stressing the 'LEE' portion. For clarity, reinforce the second syllable by slowing slightly and opening your jaw for the long /iː/ vowel.
Common mispronunciations: (1) misplacing stress on the first or third syllable instead of the second, (2) pronouncing the final 'mab' as 'map' or 'geb' due to a misread 'b' as a 'p' sound, (3) conflating /ˌæ.də/ into a clipped 'uh-da-'. Correction: mark primary stress on the second syllable /ˌæ.dəˈliː.məˌmæb/, keep the /liː/ long, and finish with a clear /mæb/ with a released /b/. Practice saying it slowly: a-dah-LEE-muh-MAB, then smooth into natural tempo.
In US English, tip the tongue toward a more rhotic, with a clear /ɹ/ not present in the word; US IPA is /ˌæ.dəˈliː.məˌmæb/. In UK English, you’ll hear a shorter /ɪ/ or /iː/ and the final /b/ is crisp; UK IPA /ˌæ.dəˈlɪ.məˌmæb/. Australian tends toward a slightly broader vowel in the /æ/ and /ə/ sequences and a less pronounced rhoticity; AU IPA /ˌæ.dəˈliː.məˌmæːb/ (data vary). The key differences are vowel height and duration in the second syllable and the final consonant clarity.
Difficult due to multi-syllabic structure and unfamiliar morpheme sequence: ada-li-mu-mab with the -mab ending that resembles other monoclonal antibody names. The sequence /ˌæ.dəˈliː.məˌmæb/ demands steady secondary stress and a long mid-vowel in the second syllable. The cluster /lm/ and the release of final /b/ can blur in rapid speech. Focus on segmenting into distinct syllables and maintaining a clear /liː/ vowel to anchor the rhythm.
A practical tip: practice chunking the name into four easy syllables with a steady beat: a-da-LI-mu-mab. Keep the /liː/ long and push the stress to the second syllable, then release the final /b/ clearly. Visualize the word as a medical term and articulate with careful mouth positions: lips neutral for /æ/, tongue high for /iː/, and a firm /b/ finish. Recording yourself helps confirm the rhythm and reduces slurring.
🗣️ Voice search tip: These questions are optimized for voice search. Try asking your voice assistant any of these questions about "Adalimumab"!
- US: rhotic? You’ll still hear /ɹ/ in surrounding context; the word itself has a neutral /ɹ/ absent. Vowel /liː/ is longer; maintain /iː/ quality by slightly rounding the lips. - UK: reduced vowel lengths in some dialects; keep /æ/ and /ə/ distinct; final /b/ is crisp. - AU: broader vowels; /æ/ can be slightly more open; /liː/ remains long; final /b/ stays a clean stop. - IPA references: US /ˌæ.dəˈliː.məˌmæb/, UK /ˌæ.dəˈlɪ.məˌmæb/, AU /ˌæ.dəˈliː.məˌmæb/. - Practical tips: practice with a mirror to monitor lip rounding; exaggerate the second syllable in practice to solidify length and stress; listen to native medical readings for rhythm.
Adalimumab is a synthetic, non-GM name constructed for a therapeutic monoclonal antibody. The suffix -mab is the standard abbreviation for monoclonal antibody. The root ada- does not reflect a natural-language root; rather, it is a fabricated sequence designed to be distinctive in pharmacology naming. The 'li' syllable group ties to the common practice of using -li- in many biologics, though its exact phonetic origin is not tied to a language root. The American naming convention often incorporates syllabic clarity to aid correct pronunciation by clinicians and patients globally. First introduced in regulatory documentation in the mid-2000s, the term Adalimumab became widely adopted with its FDA approval in 2002 (though the brand Humira entered wider use later). Over time, the word transitioned from a purely technical designation to a recognizable drug name in medical literature and patient discussions. The evolution of the name mirrors pharmaceutical branding priorities: ease of pronunciation, distinctiveness, and a hint of molecular identity through the -mab suffix. In practice, it risk-pronounceable variants exist due to the sequence -lum- and -ab, but standardized medical usage relies on IPA-based guidance across languages. While not rooted in a common etymology, the term functions as a functional lexical item within clinical discourse rather than a descriptive morpheme with semantic meaning outside its drug class.
💡 Etymology tip: Understanding word origins can help you remember pronunciation patterns and recognize related words in the same language family.
Help others use "Adalimumab" correctly by contributing grammar tips, common mistakes, and context guidance.
💡 These words have similar meanings to "Adalimumab" and can often be used interchangeably.
🔄 These words have opposite meanings to "Adalimumab" and show contrast in usage.
📚 Vocabulary tip: Learning synonyms and antonyms helps you understand nuanced differences in meaning and improves your word choice in speaking and writing.
Words that rhyme with "Adalimumab"
Practice with these rhyming pairs to improve your pronunciation consistency:
🎵 Rhyme tip: Practicing with rhyming words helps you master similar sound patterns and improves your overall pronunciation accuracy.
